Convergence research on cytological diagnosis of gynecological diseases and genital HPV : Based on data from the Obstetrics and Gynecology Department of a general hospital located in Suwon-si
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cervical cytology has been widely used as a screening tool for cervical cancer. However, Human papillomavirus (HPV) detection and subtype testing are suggested to overcome the high false-negative rate associated with cytology. We aimed to investigate the clinical usefulness and infection rate in the HPV polymerase chain reaction (PCR) test performed in hospitals. HPV PCR data from 217 patients were analyzed. Analysis of variance revealed a significant difference in the infection rate among different age groups (P=0.015). The biopsy results showed that epithelial cell abnormalities and high HPV-positivity rate was observed in 1 (100%) subject aged <29 years, in 4 out of 5 (80%) patients in their 30s, and in 3 out of 4 (75%) patients aged ≥70 years. The prevalence of HPV infection was very high (46.1%). The highest prevalence (87.5%) was observed among patients in their <29, followed by those in their 30s (67.7%) and those in their 40s (31.9%).A high rate of epithelial cell abnormalities (≥ cervical intraepithelial neoplasia type 1, mild dysplasia) was observed in HPV-infected women aged<30 years. Therefore, extensive research and prevention activities are needed in this age group. HPV PCR testing is recommended to complement cervical cytology
Abstract
Cervical cytology has been widely used as a screening tool for cervical cancer. However, Human papillomavirus (HPV) detection and subtype testing are suggested to overcome the high false-negative rate associated with cytology. We aimed to investigate the clinical usefulness and infection rate in the HPV polymerase chain reaction (PCR) test performed in hospitals. HPV PCR data from 217 patients were analyzed. Analysis of variance revealed a significant difference in the infection rate among different age groups (P=0.015). The biopsy results showed that epithelial cell abnormalities and high HPV-positivity rate was observed in 1 (100%) subject aged <29 years, in 4 out of 5 (80%) patients in their 30s, and in 3 out of 4 (75%) patients aged ≥70 years. The prevalence of HPV infection was very high (46.1%). The highest prevalence (87.5%) was observed among patients in their <29, followed by those in their 30s (67.7%) and those in their 40s (31.9%).A high rate of epithelial cell abnormalities (≥ cervical intraepithelial neoplasia type 1, mild dysplasia) was observed in HPV-infected women aged<30 years. Therefore, extensive research and prevention activities are needed in this age group. HPV PCR testing is recommended to complement cervical cytology
참고문헌 (24)
- Hyuna Sung, "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries", CA: A Cancer Journal for Clinicians, 71(3), pp.209~249 (2021), Wiley[DOI]
- Margaret E. McLaughlin-Drubin, "Viruses associated with human cancer", Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1782(3), pp.127~150 (2008), Elsevier BV[DOI]
- Jan M. M. Walboomers, "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide", The Journal of Pathology, 189(1), pp.12~19 (1999), Wiley[DOI]
- 김병기, "자궁경부암 백신접종의 최신지견", 대한의사협회지, 58(4), pp.313~318 (2015), 대한의사협회[DOI]
- Asia Asiaf, "Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection", European Journal of Cancer Prevention, 23(3), pp.206~224 (2014), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Richard Reid, "Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy", Cancer, 50(2), pp.377~387 (1982), Wiley[DOI]
- Future II Study Group, "Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions", New England Journal of Medicine, 356(19), pp.1915~1927 (2007), Massachusetts Medical Society[DOI]
- Human papillomavirus vaccines: WHO position paper, "World Health Organization", 241~268 (2017)
- Kyong-No Lee, "Attitudes Regarding HPV Vaccinations of Children among Mothers with Adolescent Daughters in Korea", Journal of Korean Medical Science, 32(1), pp.130~ (2017), Korean Academy of Medical Sciences[DOI]
- 고석봉, "대구∙경북지역에서 자궁경부암 및 전암병변에 따른 HPV 감염 빈도와 양상", Obstetrics & Gynecology Science, 51(10), pp.1128~1136 (2008), 대한산부인과학회
- AT. Lorincz, "Oncogenic Association of Specific Human Papillomavirus Types With Cervical Neoplasia<xref ref-type="fn" rid="FN1">2<", xref>, 1987, ~[DOI]
- Rengaswamy Sankaranarayanan, "HPV screening for cervical cancer in rural India", New England Journal of Medicine, 360(14), pp.1385~1394 (2009), Massachusetts Medical Society[DOI]
- Hai-Rim Shin, "Prevalence of human papillomavirus infection in women in Busan, South Korea", International Journal of Cancer, 103(3), pp.413~421 (2002), Wiley[DOI]
- Won Duk Joo, "Prevalence of Human Papillomavirus Infection in Korean Women : Risks of Abnormal Pap Smear and Cervical Neoplasia", Korean Journal of Gynecologic Oncology and Colposcopy, 15(4), pp.309~ (2004), Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy[DOI]
- S. K. Kjaer, "Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence", JNCI Journal of the National Cancer Institute, 102(19), pp.1478~1488 (2010), Oxford University Press (OUP)[DOI]
- Kimberly K. Vesco, "Risk Factors and Other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the U.S. Preventive Services Task Force", Annals of Internal Medicine, 155(10), pp.698~ (2011), American College of Physicians[DOI]
- Guglielmo Ronco, "Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials", The Lancet, 383(9916), pp.524~532 (2014), Elsevier BV[DOI]
- Hai‐Rim Shin, "Prevalence and Determinants of Genital Infection with Papillomavirus, in Female and Male University Students in Busan, South Korea", The Journal of Infectious Diseases, 190(3), pp.468~476 (2004), Oxford University Press (OUP)[DOI]
- Eduardo Lazcano‐Ponce, "Epidemiology of HPV infection among Mexican women with normal cervical cytology", International Journal of Cancer, 91(3), pp.412~420 (2001), Wiley[DOI]
- Rolando Herrero, "Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica", JNCI: Journal of the National Cancer Institute, 92(6), pp.464~474 (2000), Oxford University Press (OUP)[DOI]
- 소경아, "The Impact of High-Risk HPV Genotypes Other Than HPV 16", 18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study, 2016, pp.48(4), 1313~1320[DOI]
- 김성희, "일부 여성에서 인유두종 바이러스 감염률과 관련요인", Korean Journal of Family Medicine, 30(12), pp.972~978 (2009), 대한가정의학회
- Nubia Muñoz, "Chapter 1: HPV in the etiology of human cancer", Vaccine, 24, pp.S1~S10 (2006), Elsevier BV[DOI]
- Sue J. Goldie, "Cost-effectiveness of HPV 16, 18 vaccination in Brazil", Vaccine, 25(33), pp.6257~6270 (2007), Elsevier BV[DOI]